Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine: Persistence and Anamnestic Response to Additional Doses Administered 10 Years After Primary Vaccination.
J Infect Dis
; 224(12): 2025-2034, 2021 12 15.
Article
in En
| MEDLINE
| ID: mdl-32502272
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Adjuvants, Immunologic
/
Herpes Zoster Vaccine
/
Immunogenicity, Vaccine
/
Herpes Zoster
Type of study:
Prognostic_studies
Limits:
Aged
/
Aged80
/
Humans
/
Middle aged
Language:
En
Journal:
J Infect Dis
Year:
2021
Type:
Article
Affiliation country:
United States